Otological Side Effects of Norgesic
Norgesic (orphenadrine citrate combined with aspirin and caffeine) can cause otological side effects primarily through its aspirin component, including tinnitus and reversible hearing loss, particularly at higher doses or with prolonged use.
Primary Otological Concerns
Aspirin-Related Ototoxicity
The aspirin component in Norgesic is responsible for the main otological adverse effects 1:
- Tinnitus - Most common otological complaint
- Reversible hearing loss - Typically bilateral, mild to moderate sensorineural hearing loss
- Dose-dependent effects - Risk increases with higher serum salicylate concentrations
The mechanism involves competitive inhibition of prestin (the outer hair cell motor protein), which correlates with the reversible nature of aspirin-induced hearing loss 2. These effects typically resolve within 2-3 days after discontinuation 2.
Clinical Characteristics
Key features of aspirin ototoxicity include:
- Bilateral presentation affecting both ears
- Dose-dependency with serum concentrations of 19.6 to >67 mg/dL associated with documented ototoxicity 3
- Reversibility upon dose reduction or discontinuation
- Decreased otoacoustic emissions during active toxicity 2, 4
Orphenadrine-Specific Effects
While the FDA label for Norgesic lists general anticholinergic side effects (dizziness, light-headedness, syncope) 1, there is no specific evidence of direct ototoxicity from orphenadrine itself 5. The anticholinergic effects may cause:
- Dizziness (which could be confused with vestibular symptoms)
- Light-headedness
- Occasional confusion in elderly patients 1
Clinical Monitoring Recommendations
For patients on Norgesic therapy:
- Monitor for tinnitus development as an early warning sign
- Question patients about hearing changes at each visit
- Consider audiometric evaluation if otological symptoms develop
- Reduce dose or discontinue if ototoxicity suspected
- Expect symptom resolution within 2-3 days of discontinuation 2
Important Caveats
Risk factors for increased ototoxicity:
- Elderly patients (>59 years) 6
- Concurrent use of loop diuretics (furosemide, ethacrynic acid) 6
- Higher cumulative doses
- Prolonged therapy duration
The otological side effects are not life-threatening and typically resolve spontaneously, requiring no specific treatment beyond dose adjustment or discontinuation 2. However, they can add to patient morbidity and should be monitored, particularly in elderly patients or those on chronic therapy 3.